Search
report cover1

Targeted Therapeutics Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2024-2032

Global Targeted Therapeutics Market – Overview

Targeted therapeutics aim to treat diseases at the molecular level with precision and minimal side effects. Unlike traditional therapies that often affect healthy cells along with diseased ones, targeted therapeutics selectively act on specific molecules or pathways that are essential for disease progression. The knowledge of the molecular pathways underlying diseases is one of the pillars of targeted therapies. By identifying key molecules such as proteins, genes, or receptors involved in disease pathogenesis, researchers can develop drugs that specifically target these components.

A widely used targeted therapeutics is the use of monoclonal antibodies. These are laboratory-produced molecules that mimic the immune system’s ability to fight off harmful pathogens or abnormal cells. Through the use of genetic engineering, monoclonal antibodies can be made to recognize and attach to certain sites on cancer cells, obstructing their growth signals or designating them for immune system destruction. Another approach in targeted therapeutics involves small molecule inhibitors, which are drugs designed to interfere with specific biochemical pathways essential for disease progression. Antiviral drugs like protease inhibitors and polymerase inhibitors disrupt viral replication by targeting enzymes essential for viral proliferation.

Drugs like trastuzumab show remarkable success in treating various types of cancer, Imatinib for chronic myeloid leukemia and vemurafenib for melanoma are used as targeted therapies. Biologics, such as tumor necrosis factor (TNF) inhibitors and interleukin-6 (IL-6) provide relief for patients with conditions like rheumatoid arthritis and inflammatory bowel disease.

Currently, there are approximately 31 registered therapeutic monoclonal antibodies in the U.S. and Europe, with 160 undergoing clinical trials. Targeted therapies are part of a new approach known as personalized or precision medicine. Its use and significance is growing with time.

Global Targeted Therapeutics Market – Competitive Insights

Dec 2023 – Biomaterials-mediated targeted therapeutics of myocardial ischemia-reperfusion injury. Biomaterials are being developed to optimize the use of drugs by improving their targetability and bioavailability and reducing side effects of myocardial ischemia-reperfusion injury.

Oct 31, 2023 – Biotechnology company Vect-Horus has signed a global license agreement with Novo Nordisk for the development of targeted therapeutics.

Sep 25, 2023 –  AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, has entered into a license agreement with Takeda to develop and commercialize AcuraStem’s PIKFYVE targeted therapeutics including AS-202, an innovative antisense oligonucleotide (ASO) for the treatment of Amyotrophic Lateral Sclerosis (ALS).

Some of the Key Players in the Global Targeted Therapeutics Market Include –

  • Roche
  • Merck & Co., Inc.
  • Novartis
  • Bristol Myers Squibb (BMS)
  • AstraZeneca
  • Pfizer
  • Amgen
  • Gilead Sciences
  • Johnson & Johnson
  • AbbVie

Global Targeted Therapeutics Market – Growth Drivers

The growth of the targeted therapeutics market is driven by various factors be it from increasing molecular diseases to advanced medical technologies. Continuous advancements in molecular biology, genomics, and bioinformatics have provided deeper insights into the molecular mechanisms behind various diseases. This understanding enables the identification of novel therapeutic targets and the development of more precise targeted therapies tailored to specific molecular profiles of patients. The need for more efficient and targeted treatment choices is driven by the rising incidence of chronic diseases like cancer, heart disease, autoimmune diseases, and neurological disorders.

There is the evolution of various mutant species with time and changing environment. Many diseases, especially cancer, can develop resistance to traditional therapies over time, leading to treatment failure and disease progression. Targeted therapies can overcome or circumvent resistance mechanisms by directly targeting specific molecular vulnerabilities of cancer cells.

Global Targeted Therapeutics Market- Restraints

Targeted therapies typically target specific molecular pathways or genetic alterations, requiring a deep understanding of disease biology and molecular mechanisms. Developing drugs that selectively and effectively modulate these targets while minimizing off-target effects and toxicity can be challenging. The success of targeted therapies relies on the availability of reliable biomarkers thus in some diseases, suitable biomarkers may be scarce or inadequately validated, limiting patient stratification and hindering the widespread adoption of targeted therapies. Even though the goal of targeted therapy is to specifically inhibit disease-associated targets, off-target effects are still possible and can result in unintentional toxicity or negative reactions. The structural resemblance between the targeted molecule and other proteins may cause off-target effects, resulting in unexpected interactions.

Global Targeted Therapeutics Market – Opportunities

The shift towards personalized medicine emphasizes the importance of biomarker-driven therapies that target specific molecular alterations in individual patients. Oncology represents the largest segment of the targeted therapeutics market, driven by the growing incidence of cancer worldwide and the need for more effective and tolerable treatments. Targeted therapy drugs have been approved by the FDA to treat some types of cancer in 2023, including bladder, brain, breast, cervical, colorectal, dermatofibrosarcoma, and thyroid cancer. Advancements in drug delivery systems, such as nanoparticles and antibody-drug conjugates, enhance the efficacy and specificity of targeted treatments, opening up new market opportunities.

Global Targeted Therapeutics Market – Geographical Insights

The market for therapeutic medicines is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East, and Africa. North America holds a large targeted therapeutics market due to the high incidence of cancer in the region. As per the American Cancer Society, the number of new cancer cases in the U.S. stood at 1.95 million in 2023. According to Statistics Canada, there were 233,900 cases of cancer in 2022. The targeted therapeutics market is witnessing rapid global expansion, driven by increasing healthcare expenditure, improving access to healthcare services, and rising awareness of personalized medicine. Emerging markets in Asia-Pacific, Latin America, and the Middle East offer significant growth opportunities for pharmaceutical companies, with increasing demand for targeted therapies to address the burden of chronic diseases and infectious diseases in these regions.

Global Targeted Therapeutics Market – Key Development

  • July 13, 2023 – The principle of targeting brain circuits has drawn increasing attention with the growth of brain stimulation treatments such as transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and focused ultrasound (FUS).
  • January 2022, next-generation CD47 blocker evorpacept, manufactured by ALX Oncology for treating patients with gastroesophageal junction and gastric cancer.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly
Sample

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:

slide1

Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.

slide2

Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:

slide3

Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.

slide4

slide5

Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.

slide6

Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.

slide7

Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
Customization
small c popup.png
Complete the form below and we'll get back to you shortly
Discount
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert